Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03378739

Inova Cardiogenic Shock Registry (INOVA SHOCK)

Implementation of a Cardiogenic Shock Team and Clinical Outcomes (INOVA-SHOCK Registry)

Status
Recruiting
Phase
Study type
Observational
Enrollment
3,000 (estimated)
Sponsor
Inova Health Care Services · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers

Summary

To collect retrospective clinical outcomes related to acute decompensated heart failure cardiogenic shock, acute myocardial infarction cardiogenic shock and compare current versus historical survival rates. To collect Inova Heart and Vascular Institute (IHVI) site specific outcomes before and after initiation of the Cardiogenic Shock team on January 1, 2017. To collect outcomes related to implementation of mechanical circulatory support versus no circulatory intervention and type of intervention (extracorporeal membrane oxygenation (ECMO) versus intracorporeal axial-flow (Impella). • Assess survival at three time points.

Detailed description

Any patient with cardiogenic shock, whether inpatient or transferred from another facility, treated at the Inova Heart and Vascular Institute shall be included in this registry. This includes adults with and without decision making capacity over the age of 18 years old. The primary investigator (PI) will designate the data points to be included in the database in order to assess the efficiency of procedures and protocols in the treatment of cardiogenic shock at the IHVI as administered by the Shock team, to identify relationships between treatment and negative morbidity and mortality outcomes, and to monitor and improve quality of care delivered.

Conditions

Interventions

TypeNameDescription
PROCEDURECardiogenic Shock team activationAny patient with cardiogenic shock, whether inpatient or transferred from another facility, treated at the Inova Heart and Vascular Institute by the designated Cardiogenic Shock Team.

Timeline

Start date
2018-01-01
Primary completion
2099-12-31
Completion
2099-12-31
First posted
2017-12-20
Last updated
2026-03-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03378739. Inclusion in this directory is not an endorsement.